中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2009年
4期
392-394
,共3页
朱丽娟%颜建华%鲁志卿%高韶晖
硃麗娟%顏建華%魯誌卿%高韶暉
주려연%안건화%로지경%고소휘
视网膜母细胞瘤%非典型临床表现%诊断
視網膜母細胞瘤%非典型臨床錶現%診斷
시망막모세포류%비전형림상표현%진단
Retinoblastoma%Atypical presentation%Diagnosis
目的 分析视网膜母细胞瘤患者的非典型临床表现.以提高临床诊治水平.方法 对1995~2004年期间,中山大学中山眼科中心住院治疗的350例视网膜母细胞瘤患者的临床资料进行回顾性分析.结果 350例视网膜母细胞瘤患者中表现为白瞳者298例(85.1%),斜视29例(8.3%).非典型临床表现有:眼球震颤1例(0.3%),眼睑肿胀1例(013%),角膜水肿36例(10.3%),前房积血13(3.7%),"前房积脓"16例(4.6%),虹膜红变10例(2.9%),虹膜结节1例(0.3%).晶体混浊3例(0.9%),玻璃体积血1例(0.3%),视网膜脱离9例(2.6%),眼球痨5例(1.4%).结论 视网膜母细胞瘤具有多种临床表现,熟知其非典型临床表现可减少误诊漏诊,利于早期治疗,提高患者预后.
目的 分析視網膜母細胞瘤患者的非典型臨床錶現.以提高臨床診治水平.方法 對1995~2004年期間,中山大學中山眼科中心住院治療的350例視網膜母細胞瘤患者的臨床資料進行迴顧性分析.結果 350例視網膜母細胞瘤患者中錶現為白瞳者298例(85.1%),斜視29例(8.3%).非典型臨床錶現有:眼毬震顫1例(0.3%),眼瞼腫脹1例(013%),角膜水腫36例(10.3%),前房積血13(3.7%),"前房積膿"16例(4.6%),虹膜紅變10例(2.9%),虹膜結節1例(0.3%).晶體混濁3例(0.9%),玻璃體積血1例(0.3%),視網膜脫離9例(2.6%),眼毬癆5例(1.4%).結論 視網膜母細胞瘤具有多種臨床錶現,熟知其非典型臨床錶現可減少誤診漏診,利于早期治療,提高患者預後.
목적 분석시망막모세포류환자적비전형림상표현.이제고림상진치수평.방법 대1995~2004년기간,중산대학중산안과중심주원치료적350례시망막모세포류환자적림상자료진행회고성분석.결과 350례시망막모세포류환자중표현위백동자298례(85.1%),사시29례(8.3%).비전형림상표현유:안구진전1례(0.3%),안검종창1례(013%),각막수종36례(10.3%),전방적혈13(3.7%),"전방적농"16례(4.6%),홍막홍변10례(2.9%),홍막결절1례(0.3%).정체혼탁3례(0.9%),파리체적혈1례(0.3%),시망막탈리9례(2.6%),안구로5례(1.4%).결론 시망막모세포류구유다충림상표현,숙지기비전형림상표현가감소오진루진,리우조기치료,제고환자예후.
Objective To study the atypical presenting signs of retinoblastoma in our institution. Methods A retrospective study was performed on the records of 350 patients treated for retinoblastoma at Zhongshan Ophthalmic Center between 1994 and 2005.Results A total records of 350 cases of retinoblas-toma were reviewed.85.1% of the patients had leukocoria, 8.3% of the patients had strabismus.Uncommon presenting signs include: nystagmus (0.3%), eyelid swelling (0.3%), corneal edema (10.3%), hyphema (3.7%), pseudohypopyon (4.6%), iris neovascularization (2.9%),iris nodules (0.3%), cataract (0.3%),vilreous hemorrhage (0.3%),retina detachment (2.6%),phthisis bulbi (1.4%).Conclusions Varied presentations of retinoblastoma, especially atypical presentation should alert the clinician to suspect retinoblastoma.